Is Transmural Healing an Achievable Goal in Inflammatory Bowel Disease?

Pharmaceuticals (Basel) · 2025 · PMC12389124 · PMID 40872518

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

did not reach statistical significancep = 0.054so close (0.05 < p ≤ 0.1)

In contrast, for the presence of small bowel disease, specificity was 96% (95% CI, 86–99) with MRE and 84% [95% CI, 65–94] with IUS, a difference that did not reach statistical significance ( p = 0.054) [ 48 ]. 3.2.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.